We are live on
!
Find out more
CBIO
Crescent Biopharma
CBIO
CBIO
31 hedge funds and large institutions have $109M invested in Crescent Biopharma in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
225% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 4
11% more funds holding
Funds holding: 28 → 31 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less capital invested
Capital invested by funds: $114M → $109M (-$4.93M)
Holders
31
Holders Change
+3
Holders Change %
+10.71%
% of All Funds
0.84%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
13
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
JP Morgan Chase
New York
|
-$628K |
| 2 |
SIM
Spark Investment Management
New York
|
-$130K |
| 3 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$51.3K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$16.5K |
| 5 |
Citigroup
New York
|
-$12.4K |
